arrow
M

Marco Grillini

IRCCS Azienda Ospedaliero-Universitaria di Bologna
H指数:12
被引数:411

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pattern‐based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements

基于模式对卵巢畸胎瘤中<scp>SOX2</scp>表达的解读:区分未成熟与成熟神经外胚层成分以避免诊断陷阱

2026-08-210
OAAI
Genome-Wide Single-Nucleotide Polymorphism (SNP)-based Profiling of Loss of Heterozygosity Reveals Distinct Molecular Subgroup-Specific Patterns in Gastrointestinal Stromal Tumors (GIST)

全基因组单核苷酸多态性(SNP)为基础的杂合性丢失(LOH)分析揭示胃肠道间质瘤(GIST)中特异的分子亚组特异性模式

2026-06-230
OAAI
Performance and clinical utility of two targeted multigene panels for GIST molecular characterization

两种靶向多基因panel在GIST分子特征分析中的性能与临床应用价值

2025-12-170
OAAI
Correction to: The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor

更正:在来源于生殖细胞的血管发生性间质病变中,FOXA2和HNF1β表达缺失,提示其可能遵循与肉瘤样卵黄囊瘤相似的进化途径。

2025-09-050
OA
The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor

FOXA2和HNF1β在血管发生性间质病变中的缺失,提示其可能遵循与肉瘤样卵黄囊肿瘤相似的进化途径。

2025-08-180
PRE
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype

子宫内膜癌与免疫逃逸:HLA I类分子丢失在NSMP亚型中的预后相关性

2025-08-120
OAAI
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment

基于灌注的冷冻卵巢癌组织离体培养,保留肿瘤微环境

2025-05-230
OA
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites
2025-02-200
OAAI
Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and 'somatic-type' adenocarcinoma

免疫表型评估支持生殖细胞起源的化疗后腺体肿瘤跨越腺卵黄囊肿瘤和 “体细胞型” 腺癌之间

2024-07-011
PRE
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT

评估一系列机构的肾脏低度嗜酸细胞肿瘤 (LOT),并回顾LOT的突变情况

2023-10-176
OAAI
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

子宫内膜癌分子亚型中病理特征的预后意义

2023-04-257
OAAI
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
2023-03-3015
OAAI
Relevance of ARID1A Mutations in Endometrial Carcinomas
2022-02-258
OAAI